Advicenne Pharmaceuticals' Series A Round

Advicenne Pharmaceuticals raised a round of funding on March 20, 2017.

Advicenne is a pharmaceutical company that develops drugs for children with neurological disorders such as epilepsy as well as renal or orphan diseases. The Company's products and treatments are safe,…

Articles about Advicenne Pharmaceuticals' Series A Round: